← Back to Search

Telemonitoring for Heart Failure

N/A
Recruiting
Led By Martin Cadeiras, MD
Research Sponsored by University of California, Davis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
HF stage B-D and class I-IV
Diagnosis of Heart failure
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one year from enrollment
Awards & highlights

Study Summary

This trial will test whether using data from different 'omics' studies can help identify people at risk for heart failure, and whether a telemonitoring intervention can help optimize their care.

Who is the study for?
This trial is for individuals with heart failure who have evidence of cardiac issues or high levels of a specific heart stress marker. They must be in any stage or class of heart failure, able to consent, follow the study's protocol, use a smartphone regularly, and not have had a heart transplant or mechanical circulatory support.Check my eligibility
What is being tested?
The study is exploring if advanced testing can predict which patients with heart failure are at higher risk and whether monitoring these patients using telemonitoring devices can help optimize their treatment according to established guidelines.See study design
What are the potential side effects?
Since this trial involves telemonitoring devices rather than medication, side effects may include discomfort from wearing the device and potential privacy concerns related to data transmission. There might also be psychological impacts due to constant health monitoring.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My heart failure is between stages B to D and class I to IV.
Select...
I have been diagnosed with heart failure.
Select...
I have heart issues shown by tests or high BNP levels.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~five years from enrollment
This trial's timeline: 3 weeks for screening, Varies for treatment, and five years from enrollment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Rate of adverse outcomes in heart failure
Secondary outcome measures
Disease progression
Other outcome measures
Percentage of guideline-directed medical therapy (GDMT).

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: TelemonitoringExperimental Treatment1 Intervention
Blood pressure and heart rate monitoring, scale, activity tracker.
Group II: No interventionActive Control1 Intervention
No intervention.

Find a Location

Who is running the clinical trial?

University of California, DavisLead Sponsor
909 Previous Clinical Trials
4,704,030 Total Patients Enrolled
6 Trials studying Heart Failure
2,490 Patients Enrolled for Heart Failure
Martin Cadeiras, MDPrincipal InvestigatorUniversity of California, Davis
1 Previous Clinical Trials
34 Total Patients Enrolled

Media Library

Telemonitoring devices Clinical Trial Eligibility Overview. Trial Name: NCT04196842 — N/A
Heart Failure Research Study Groups: No intervention, Telemonitoring
Heart Failure Clinical Trial 2023: Telemonitoring devices Highlights & Side Effects. Trial Name: NCT04196842 — N/A
Telemonitoring devices 2023 Treatment Timeline for Medical Study. Trial Name: NCT04196842 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many individuals are taking part in this clinical research?

"Correct. According to clinicaltrials.gov, this medical study is still actively recruitment participants as of February 1st 2022 - the date of its last update. The trial was first posted on October 16th 2019 and seeks to enrol 100 individuals at one single location."

Answered by AI

Are there any opportunities for individuals to actively participate in this research endeavor?

"Affirmative. Clinicaltrials.gov data reveals that this experiment is recruiting, having been initially posted on October 16th 2019 and most recently updated on February 1st 2022. The research team needs to locate 100 subjects from a single site."

Answered by AI
~18 spots leftby Mar 2025